I kliniske forsøg, der inkluderer patienter med type 2 diabetes, der ikke var velkontrollerede på orale m
ra In clinical trials involving patients with type 2 diabetes not sufficiently controlled with oral agents alone, patients using a regimen of EXUBERA alone or in combination with oral agents, had greater